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William H. Gaasch, MD,y Gerard P. Aurigemma, MDzP ressure overload of the left ventricle as occursin systemic arterial hypertension and aorticstenosis generally results in an adaptive
left ventricular (LV) hypertrophic remodeling in a
concentric pattern (1). This pattern is deﬁned by an
increased LV wall thickness or wall mass with a
normal end diastolic volume (2). However, not all
pressure overload results in such concentric remodel-
ing of the ventricle. For example, some patients with
hypertension (HTN) exhibit an eccentric remodeling
pattern with normal systolic function (3). Other pa-
tients with aortic stenosis seem to maintain normal
LV systolic performance despite the lack of a compen-
satory hypertrophic response (4). Still others with
pressure overload hypertrophy and normal LV global
function exhibit abnormalities of regional function
(5). Recognizing the importance of these and other
studies of LV volume, mass, and function in left ven-
tricular hypertrophy (LVH), it is relevant to examine
the changes that develop in the cardiac interstitium
and to relate the ﬁndings to other pathophysiological
data, clinical outcomes, and therapeutic interven-
tions (6).SEE PAGE 172In this issue of iJACC, Kuruvilla et al. (7) used
cardiac magnetic resonance (CMR) imaging tech-
niques to describe an association between extra-
cellular volume (ECV, a surrogate for interstitial
ﬁbrosis) and myocardial shortening and lengthening*Editorials published in JACC: Cardiovascular Imaging reﬂect the views of
the authors and do not necessarily represent the views of JACC:
Cardiovascular Imaging or the American College of Cardiology.
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the contents of this paper to disclose.parameters (systolic and diastolic strains). They
studied a relatively small number of hypertensive
patients, some with and some without LVH, and a
control group of healthy volunteers. They found that
the ECV was signiﬁcantly higher in the group with
hypertension and hypertrophy (HTN þ LVH) than in
the other 2 groups. This increase in ECV, implying
ﬁbrosis, was associated with reduced myocardial
shortening (systolic strain) in both circumferential
and radial planes; it was also associated with reduced
lengthening rate (diastolic strain rate). These strains
show considerable variability, but they do exhibit
statistically signiﬁcant correlations with the
increased ECV. Obviously such associations and cor-
relations do not prove cause and effect, but they do
conﬁrm data published by others and they emphasize
the potential that CMR holds for studies of cardiac
remodeling.
In patients with HTN, the increase in LV wall mass
and the “diffuse ﬁbrosis” reported by Kuruvilla et al.
(7) produces a substrate for diastolic dysfunction and
diastolic heart failure. It should be emphasized,
however, that the diastolic properties of the myocar-
dium are not determined only by the volume of the
ECV. The composition of the ECV is also important.
For example, ﬁbrillar components (collagen, elastin),
basement membrane proteins (laminin, ﬁbronectin),
and nonﬁbrillar components, as well as the nature and
extent of collagen cross linking all play a role in
determining myocardial stiffness. It should also be
recognized that isoform switches and the phosphor-
ylation state of titin within the cardiomyocyte affect
myocardial passive stiffness. Indeed, some experi-
mental data indicate that increased titin-based stiff-
ness is sufﬁcient to cause diastolic dysfunction in
the absence of changes in the extracellular matrix
composition or matrix-based stiffness (8).
Certainly, the passive stiffness of the whole
ventricle is inﬂuenced by the stiffness of the LV wall
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182(combined stiffness of the myocytes and the inter-
stitium), but it should also be emphasized that LV
stiffness is affected by the ratio of LV wall mass to
chamber volume (M/V). A large body of literature
developed over the past several decades indicates
that the M/V in normal hearts ranges from 1 to 1.5 (2).
Deviations from this normal range are generally
determined by the type of LV overload or injury so
that the ratio tends to be low in dilated cardiomyop-
athy or chronic mitral regurgitation (eccentric
remodeling/hypertrophy) and high in aortic stenosis
or systemic arterial hypertension (concentric remod-
eling/hypertrophy).
In the paper by Kuruvilla et al. (7), the HTN þ LVH
group exhibited an M/V ratio that was greater than
that seen in the normal control group, but the values
in all 3 groups are lower than expected and less
than that reported by others using similar CMR
techniques (9). The low M/V cannot be explained
by an increased end-diastolic volume because the
volume (approximately 65 ml/m2 body surface area
in all 3 groups) was well within the range of normal.
By contrast, the LV mass in the control group was
relatively low (49 g/m2) and only mildly increased in
the HTN þ LVH group (83 g/m2). Measurements of LV
mass and especially the M/V ratio vary considerably
depending on whether or not the trabecular and
papillary muscle mass is or is not included in the
calculation of wall mass (10,11). This issue may be a
problem in other published studies, but it is unlikely
to explain the low M/V ratios described by Kuruvilla
et al. (7) because they speciﬁed that the papillary
muscle mass was included in the total wall mass.
Thus, the low M/V ratios in this study are a conse-
quence of a low LV mass which is unexplained. This is
an important issue because ECV (expressed as a
percent of the LV mass) will be overestimated if the
mass calculations underestimate the true LV wall
mass.
Regional strain abnormalities in hypertrophic heart
disease have been described by others, but the cause
of such abnormalities remains uncertain. It has not
been established whether the strain abnormalities
seen in LVH are a consequence of the LV geometricremodeling and load changes or a true functional
abnormality (12,13). It is possible that alterations in
myocardial calcium homeostasis, which is disturbed
in LVH, might contribute to abnormal myocardial
strains. It is also possible that the tethering effect of a
ﬁbrotic interstitium on the cardiomyocytes might
affect strain.
It should also be recognized that all strain mea-
surements, both linear strains (eg, myocardial short-
ening and lengthening) and volume strains (eg, LV
ejection fraction and ﬁlling rate), are inﬂuenced by
the prevailing hemodynamic loads. Loading condi-
tions affect strain measurements made by contrast or
radionuclide angiography, echocardiography, as well
as CMR. As a result, chamber ﬁlling and myocardial
lengthening rates have largely been discarded in
clinical research because of their well-recognized
load dependency (14,15). Strain abnormalities in
LVH may indicate that something is amiss, but the
mechanisms that underlie such changes in regional
strain remain to be isolated and clariﬁed.
If the composition of the ECV could be better
deﬁned, the measurement of this space with CMR
might be more meaningful and potentially useful in
studies of patients with heart failure, particularly
those with diastolic heart failure. For example, an
increased ECV could be a relatively stable clue to
the presence of diastolic dysfunction (in contrast
to echocardiographic and other dynamic indices of
diastolic function that are sensitive to a variety of
hemodynamic loads). An increase in ECV might be
of diagnostic value if it could conﬁrm a cardiac
abnormality that is not apparent in a patient with a
normal LV mass and inconclusive Doppler echocar-
diographic data. Therapeutic trials could use CMR to
follow changes in the ECV. Recognizing that addi-
tional reﬁnement and validation is necessary, CMR
assessment of the interstitium will continue to play
a signiﬁcant role in clinical investigation.
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